Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
Neisseria meningitidis is associated with high mortality and morbidity in infants and children worldwide. This phase 3 study (NCT02173704) evaluated safety and immunogenicity of a 4-component serogroup B recombinant meningococcal vaccine (4CMenB) co-administered with routine vaccines in Taiwanese in...
Saved in:
Main Authors: | Nan-Chang Chiu (Author), Li-Min Huang (Author), Arnold Willemsen (Author), Chiranjiwi Bhusal (Author), Ashwani Kumar Arora (Author), Zenaida Reynoso Mojares (Author), Daniela Toneatto (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines
by: Priya Pereira, et al.
Published: (2020) -
Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
by: Véronique Abitbol, et al.
Published: (2023) -
Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017) -
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023) -
Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study
by: Franco M. Piazza, et al.
Published: (2022)